应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02410 同源康医药 -B
休市中 08-16 16:00:00
0.000
+0.000
--
最高
0.000
最低
0.000
成交量
0.00
今开
0.000
昨收
0.000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
3.71亿
成交额
0.00
换手率
0.00%
流通股本
1.93亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
下周备忘
阿斯达克财经 · 08-16 18:05
下周备忘
“三无”公司开启IPO路演,同源康医药两年亏6.9亿
地产k线 · 08-14
“三无”公司开启IPO路演,同源康医药两年亏6.9亿
同源康医药-B(02410.HK)这票打不打?
行业报告研究院 · 08-13
同源康医药-B(02410.HK)这票打不打?
同源康医药公开招股,引入长兴国资为基石,预计8月20日挂牌上市
独角兽早知道 · 08-13
同源康医药公开招股,引入长兴国资为基石,预计8月20日挂牌上市
港股IPO动态:今日同源康医药申购
格隆汇 · 08-13
港股IPO动态:今日同源康医药申购
新股公告 | 同源康医药-B今起招股,入场费6111港元
老虎资讯综合 · 08-12
新股公告 | 同源康医药-B今起招股,入场费6111港元
同源康医药-B拟全球发售4788万股 每股定价12.1港元
观点新媒体 · 08-12
同源康医药-B拟全球发售4788万股 每股定价12.1港元
同源康医药-B(02410.HK)8月12日起招股 发售价将为每股12.1港元
格隆汇 · 08-12
同源康医药-B(02410.HK)8月12日起招股 发售价将为每股12.1港元
IPO雷达|同源康医药赴港上市:无商业化产品,与汇宇制药先订立关联交易合同
界面 · 08-09
IPO雷达|同源康医药赴港上市:无商业化产品,与汇宇制药先订立关联交易合同
同源康医药IPO,蒙上了创新药研发的“阴影”
港股研究社 · 08-07
同源康医药IPO,蒙上了创新药研发的“阴影”
同源康医药赴港IPO,估值超30亿,资金压力巨大
IPO那点事 · 08-07
同源康医药赴港IPO,估值超30亿,资金压力巨大
同源康医药再冲刺上市:正在浙江湖州建厂,中金为其股东
贝多财经 · 07-30
同源康医药再冲刺上市:正在浙江湖州建厂,中金为其股东
估值增长近23倍!创始人套现,同源康医药亏损难题待解!
市场资讯 · 07-30
估值增长近23倍!创始人套现,同源康医药亏损难题待解!
新股消息 | 同源康医药再次递表港交所 截至3月末公司仍处持续亏损状态
智通财经APP · 07-30
新股消息 | 同源康医药再次递表港交所 截至3月末公司仍处持续亏损状态
加载更多
公司概况
公司名称:
同源康医药 -B
所属市场:
SEHK
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药 -B","latestPrice":0,"timestamp":1723795200000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":192586173,"shares":370835818,"eps":0,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"08-16 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"ipoDetail":{"name":"同源康医药-B","exchange":"SEHK","listingDate":"2024-08-20","sharesOutstanding":370835818,"sharesFloat":192586173,"offerAmount":47880000,"priceRange":"12.10","market":"HK","openProspectusDate":"2024-08-12","openProspectusUrl":"https://staticpdf.iqdii.com/stockdata/notice/02410/2024/2024081200006_c.pdf","purchaseBeginDate":"2024-08-12","purchaseEndDate":"2024-08-15","winningDate":"2024-08-19","currency":"HKD","minPurchaseQuantity":500,"use":"1、70.0%或约354.4百万港元将用于核心产品(即TY-9591)的研究、开发 及商业化;\n2、20.0%或约101.3百万港元将用于其他候选产品的研发;\n3、3.0%或约15.2百万港元将用于潜在的战略收购、投资、许可或合作机会;\n4、7.0%或约35.4百万港元将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家临床阶段的生物制药公司,致力于发现、收购、开发差异化靶向治疗并对其进行商业化,以满足癌症治疗中亟待满足的医疗需求。","subscribed":0.3,"marketCap":4487000000,"minimumCapital":6111.01,"overAllotment":false,"lotSize":500,"issueOpenRate":0.1,"subscribeGear":"500,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1250000,1500000,1750000,2000000,2394000"},"greyMarketDetail":{"greyDate":"2024-08-19","greyDateTimestamp":1723996800000,"greyOpeningTime":1724055300000,"greyClosingTime":1724063400000,"showGreyQuote":false,"openProspectusDate":"2024-08-12","listingDate":"2024-08-20"},"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1723771800000,1723780800000],[1723784400000,1723795200000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410","defaultTab":"news","newsList":[{"id":"2459995972","title":"下周备忘","url":"https://stock-news.laohu8.com/highlight/detail?id=2459995972","media":"阿斯达克财经","labels":["Economic Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459995972?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:05","pubTimestamp":1723802700,"startTime":"0","endTime":"0","summary":"8月19日(周一)新西兰7月央行服务业表现指数:前值40.2日本6月核心机械订单月率:预测转升0.9%;前值跌3.2%日本6月核心机械订单年率:预测升1.1%;前值升10.8%英国8月Rightmove房价指数年率:前值升0.4%英国8月Rightmove房价指数月率:前值跌0.4%美国7月咨商会领先指标:预测跌0.3%;前值跌0.2%业绩公布:恒安国际(01044.HK)、华润啤酒(00291.","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180504113903359_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180504113903359_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1372387&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Economic Data","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09698","00511","01224","01833","00388","02688","02382","06969","00069","01071","01044","00548","02878","03808","02367","06979","09997","00081","02018","02057","02899","00386","02096","02380","00780","02778","09979","09690","00173","00425","01033","03668","02480","01036","03311","06098","02869","09969","01530","01962","09992","01368","00097","02410","01816","01070"],"gpt_icon":1},{"id":"2459198098","title":"“三无”公司开启IPO路演,同源康医药两年亏6.9亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2459198098","media":"地产k线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459198098?lang=zh_cn&edition=full","pubTime":"2024-08-14 10:32","pubTimestamp":1723602738,"startTime":"0","endTime":"0","summary":"同源康医药发行价为12.1港元,拟2024年8月20日在港交所上市。据招股书,截至最后实际可行日期,同源康医药尚未从商业化产品的销售中产生任何收入,且继续产生与持续经营相关的重大研发成本及其他开支。因此,其并无盈利,且自成立以来已产生重大净亏损。截至2022年及2023年12月31日止年度以及截至2024年3月31日止三个月,同源康医药的净亏损分别为3.12亿元、3.83亿元及1.08亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408141034249f290755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408141034249f290755&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","BK1515","BK1574","02410"],"gpt_icon":0},{"id":"2459928645","title":"同源康医药-B(02410.HK)这票打不打?","url":"https://stock-news.laohu8.com/highlight/detail?id=2459928645","media":"行业报告研究院","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459928645?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:49","pubTimestamp":1723535398,"startTime":"0","endTime":"0","summary":"截至2024年3月31日,公司账上现金7720.8万,预付款项及其他应收款项4808.9万。且看我下面的分析:同源康医药在上市前经历了6轮融资,融资总金额超过了人民币9.49亿元;2023年12月完成D轮融资,已付的每股成本约人民币9.55元,投后估值约人民币30.84亿元募资发行比例12.91%,募资金额5.79亿港元,h股流通市值基23.3亿左右,算是一个中等规模的票了。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131554419f26ae7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131554419f26ae7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02410","BK1515","BK1574"],"gpt_icon":0},{"id":"2459949949","title":"同源康医药公开招股,引入长兴国资为基石,预计8月20日挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2459949949","media":"独角兽早知道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459949949?lang=zh_cn&edition=full","pubTime":"2024-08-13 14:25","pubTimestamp":1723530311,"startTime":"0","endTime":"0","summary":"同源康医药-B发布公告,公司拟全球发售股份4788万股,中国香港发售股份478.8万股,国际发售股份4309.2万股;2024年8月12日至8月15日招股;发售价将为每股H股12.10港元,中信证券为独家保荐人;预期股份将于2024年8月20日开始在联交所主板买卖。同源康医药本次香港IPO将收取的全球发售净所得款项约为5.06亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081314354895946429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081314354895946429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02410","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2459996583","title":"港股IPO动态:今日同源康医药申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2459996583","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459996583?lang=zh_cn&edition=full","pubTime":"2024-08-13 06:11","pubTimestamp":1723500678,"startTime":"0","endTime":"0","summary":"格隆汇8月13日|今日同源康医药-B(2410.HK)申购,无新股上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130611259f25695f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130611259f25695f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","02410","HSTECH","BK1515","BK1574","BK1161","09939"],"gpt_icon":1},{"id":"1181126580","title":"新股公告 | 同源康医药-B今起招股,入场费6111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181126580","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181126580?lang=zh_cn&edition=full","pubTime":"2024-08-12 10:04","pubTimestamp":1723428244,"startTime":"0","endTime":"0","summary":"8月12日, 同源康医药-B发布公告,将于8月12日-8月15日招股,拟全球发售4788万股股份,公开发售478.8万股,国际发售4309.2万股,每股发行价12.10港元,每手500股,预计于8月20日上市。乙组门槛为50万股,申购所需资金约611.1万港元。同源康医药于2022年、2023年及截至2024年3月31日止三个月的研发成本分别约为2.30亿元、2.49亿元及6469.9万元。筹资用途筹资用途方面,同源康医药预计全球发售所得款项净额约5.06亿港元。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/11a306c6362cd6263bbd3c40563bc646","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/11a306c6362cd6263bbd3c40563bc646"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股公告 | 同源康医药-B今起招股,入场费6111港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410","09939","BK1515","159938","BK1574"],"gpt_icon":0},{"id":"2458285076","title":"同源康医药-B拟全球发售4788万股 每股定价12.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458285076","media":"观点新媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458285076?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:12","pubTimestamp":1723425130,"startTime":"0","endTime":"0","summary":"观点网讯:8月12日,同源康医药-B宣布,公司计划于2024年8月12日至8月15日进行公开招股,全球发售股份总数为4788万股。根据分配计划,香港市场将获得10%的股份,而国际市场将获得剩余的90%股份。每股的定价定为12.1港元,每手交易单位设定为500股。同源康医药-B预计其H股将于2024年8月20日(星期二)上午九时正(香港时间)在联交所开始交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120913169590f448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120913169590f448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02410","BK1515","BK1574"],"gpt_icon":0},{"id":"2458861196","title":"同源康医药-B(02410.HK)8月12日起招股 发售价将为每股12.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458861196","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458861196?lang=zh_cn&edition=full","pubTime":"2024-08-12 06:25","pubTimestamp":1723415108,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/J9CD3JQG05198ETO.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.163.com/dy/article/J9CD3JQG05198ETO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02410"],"gpt_icon":0},{"id":"2458560937","title":"IPO雷达|同源康医药赴港上市:无商业化产品,与汇宇制药先订立关联交易合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2458560937","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458560937?lang=zh_cn&edition=full","pubTime":"2024-08-09 20:40","pubTimestamp":1723207200,"startTime":"0","endTime":"0","summary":"同源康医药作为临床阶段的生物制药企业,专注于差异化靶向疗法的研发与商业化,目前尚无商业化产品,公司面临高额研发支出与资金需求的双重压力,报告期内亏损扩大。由于同源康医药目前并无获准进行商业销售的产品。对于选择汇宇制药的原因,同源康医药表示:为促进TY-9591的商业化上市,并确保从实验室规模开发无缝过渡至正式商业生产,公司需要扩大其生产规模并简化监管批准的途径。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809204156958be6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809204156958be6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","688553","BK0239","159938"],"gpt_icon":0},{"id":"2457814402","title":"同源康医药IPO,蒙上了创新药研发的“阴影”","url":"https://stock-news.laohu8.com/highlight/detail?id=2457814402","media":"港股研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457814402?lang=zh_cn&edition=full","pubTime":"2024-08-07 19:18","pubTimestamp":1723029522,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/J90T90SU05317SYF.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.163.com/dy/article/J90T90SU05317SYF.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02410"],"gpt_icon":0},{"id":"2457838878","title":"同源康医药赴港IPO,估值超30亿,资金压力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2457838878","media":"IPO那点事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457838878?lang=zh_cn&edition=full","pubTime":"2024-08-07 08:08","pubTimestamp":1722989289,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/J8VN0KV205397AW5.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.163.com/dy/article/J8VN0KV205397AW5.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02410"],"gpt_icon":0},{"id":"2455690869","title":"同源康医药再冲刺上市:正在浙江湖州建厂,中金为其股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2455690869","media":"贝多财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455690869?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:50","pubTimestamp":1722347458,"startTime":"0","endTime":"0","summary":"近日,浙江同源康医药股份有限公司-B(下称“同源康医药”)再次递交招股书,准备在港交所主板上市,中信证券为其独家保荐人。据贝多财经了解,该公司曾于2024年1月26日向港交所递交过上市申请。相较于此前招股书,同源康医药补充披露了截至2024年第一季度的财务数据等信息。截至目前,该公司暂未产生收入。2024年第一季度...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OM1Fe7SHdnf0VVdsRrKzIHG1hhzZ-wQ5n7P2zHlgiPMAIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OM1Fe7SHdnf0VVdsRrKzIHG1hhzZ-wQ5n7P2zHlgiPMAIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240730A09QE700","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240730A09QE700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1515","02410","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2455980427","title":"估值增长近23倍!创始人套现,同源康医药亏损难题待解!","url":"https://stock-news.laohu8.com/highlight/detail?id=2455980427","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455980427?lang=zh_cn&edition=full","pubTime":"2024-07-30 19:11","pubTimestamp":1722337860,"startTime":"0","endTime":"0","summary":" 据港交所,近期,浙江同源康医药股份有限公司通过聆讯,由中信证券独家保荐,通过18A规则申请IPO。 同源康医药是一家位于浙江省湖州市的生物制药公司,成立于2017年11月,专注于小分子药物和其他相关创新药物种类的发现、开发及商业化,主要解决癌症领域特别是肺癌领域未满足的医疗需求。 5年获得6轮融资,同源康医药的估值大幅增长。截至2023年三季度末,同源康医药权益股份赎回负债项的对应金额为9.70亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hyyj/2024-07-30/doc-incfxkzz9933451.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2024-07-30/doc-incfxkzz9933451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02410","09939","BK1515","159938","BK1574"],"gpt_icon":0},{"id":"2455891330","title":"新股消息 | 同源康医药再次递表港交所 截至3月末公司仍处持续亏损状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2455891330","media":"智通财经APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455891330?lang=zh_cn&edition=full","pubTime":"2024-07-30 17:09","pubTimestamp":1722330540,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3ODE2MTM0Ng==&mid=2651481899&idx=2&sn=e4bd2b57054a21024fe8c9ea1f9c9bb6&chksm=856f95555661ea9ca7785f20d3da512303afd049be5a691928d350612a263db3c1a6bc2538bb&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02410"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.1086},{"period":"6month","weight":0.0667},{"period":"1year","weight":-0.0489},{"period":"ytd","weight":0.0225}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"exchange":"SEHK","name":"同源康医药 -B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药 -B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药 -B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药 -B,02410,同源康医药 -B股票,同源康医药 -B股票老虎,同源康医药 -B股票老虎国际,同源康医药 -B行情,同源康医药 -B股票行情,同源康医药 -B股价,同源康医药 -B股市,同源康医药 -B股票价格,同源康医药 -B股票交易,同源康医药 -B股票购买,同源康医药 -B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药 -B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药 -B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}